KVÅKVÅ3E030U1 — Introduction of Nonautologous Pancreatic Islet Cells into Peripheral Vein, Open Approach
KVÅKVÅ3E033U1 — Introduction of Nonautologous Pancreatic Islet Cells into Peripheral Vein, Percutaneous Approach
KVÅKVÅ3E0J3U1 — Introduction of Nonautologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Percutaneous Approach
KVÅKVÅ3E0J7U1 — Introduction of Nonautologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
KVÅKVÅ3E0J8U1 — Introduction of Nonautologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic
KVÅKVÅ3E0P3Q1 — Introduction of Nonautologous Fertilized Ovum into Female Reproductive, Percutaneous Approach
KVÅKVÅ3E0P7Q1 — Introduction of Nonautologous Fertilized Ovum into Female Reproductive, Via Natural or Artificial Opening
KVÅKVÅ3E0Q0E1 — Introduction of Nonautologous Somatic Stem Cells into Cranial Cavity and Brain, Open Approach
KVÅKVÅ3E0Q3E1 — Introduction of Nonautologous Somatic Stem Cells into Cranial Cavity and Brain, Percutaneous Approach
KVÅKVÅ3E0R3E1 — Introduction of Nonautologous Somatic Stem Cells into Spinal Canal, Percutaneous Approach
KVÅKVÅ3E00X05 — Introduction of Other Antineoplastic into Skin and Mucous Membranes, External Approach
KVÅKVÅ3E00X0M — Introduction of Antineoplastic, Monoclonal Antibody, into Skin and Mucous Membranes, External Approach
KVÅKVÅ3E00X29 — Introduction of Other Anti-infective into Skin and Mucous Membranes, External Approach
KVÅKVÅ3E00X4Z — Introduction of Serum, Toxoid and Vaccine into Skin and Mucous Membranes, External Approach
KVÅKVÅ3E00XGC — Introduction of Other Therapeutic Substance into Skin and Mucous Membranes, External Approach
KVÅKVÅ3E00XKZ — Introduction of Other Diagnostic Substance into Skin and Mucous Membranes, External Approach
KVÅKVÅ3E00XNZ — Introduction of Analgesics, Hypnotics, Sedatives into Skin and Mucous Membranes, External Approach
KVÅKVÅ3E0130M — Introduction of Antineoplastic, Monoclonal Antibody, into Subcutaneous Tissue, Percutaneous Approach
KVÅKVÅ3E0132A — Introduction of Anti-Infective Envelope into Subcutaneous Tissue, Percutaneous Approach
KVÅKVÅ3E0134Z — Introduction of Serum, Toxoid and Vaccine into Subcutaneous Tissue, Percutaneous Approach
KVÅKVÅ3E0136Z — Introduction of Nutritional Substance into Subcutaneous Tissue, Percutaneous Approach
KVÅKVÅ3E0137Z — Introduction of Electrolytic and Water Balance Substance into Subcutaneous Tissue, Percutaneous Approach
KVÅKVÅ3E013GC — Introduction of Other Therapeutic Substance into Subcutaneous Tissue, Percutaneous Approach
KVÅKVÅ3E013HZ — Introduction of Radioactive Substance into Subcutaneous Tissue, Percutaneous Approach
KVÅKVÅ3E013KZ — Introduction of Other Diagnostic Substance into Subcutaneous Tissue, Percutaneous Approach
KVÅKVÅ3E013NZ — Introduction of Analgesics, Hypnotics, Sedatives into Subcutaneous Tissue, Percutaneous Approach
KVÅKVÅ3E0230M — Introduction of Antineoplastic, Monoclonal Antibody, into Muscle, Percutaneous Approach
KVÅKVÅ3E0237Z — Introduction of Electrolytic and Water Balance Substance into Muscle, Percutaneous Approach
